Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
May 2027 82
2027-05-01
Study completion Efficacy of Montelukast on STEMl Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07320625
2027-05-01
Primary completion Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07441382
2027-05-01
2027-05-01
Primary completion EECP for Erectile Dysfunction in Elderly Hypertensive Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07831551
2027-05
Study completion A Study of the ReCor Medical Paradise System in Clinical Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02649426
2027-05
Primary completion Endovascular Acute Stroke Intervention - Tandem OCclusion Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04261478
2027-05
2027-05
2027-05
2027-05
Primary completion Semaglutide to Reduce Atrial Fibrillation Burden Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05209165
2027-05
Primary completion GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05356104
2027-05
Primary completion Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05378347
2027-05
2027-05
2027-05
2027-05
2027-05
2027-05
2027-05
Study completion Heart Failure Management for Patient With CIED Remotely Monitored Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07247032
2027-05
Primary completion Heart Failure Management for Patient With CIED Remotely Monitored Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07247032
2027-05
Primary completion Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07267949
2027-05
Study completion Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07487103
2027-05
2027-05
Study completion A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07613307
2027-05
Primary completion A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07613307
2027-05
2027-05-02
2027-05-03
Primary completion The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05464095
2027-05-05
Study completion Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04561739
2027-05-08
Primary completion Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06281977
2027-05-10
2027-05-10
2027-05-10
2027-05-10
Primary completion To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05426785
2027-05-12
2027-05-15
2027-05-16
2027-05-17
2027-05-17
2027-05-20
2027-05-22
2027-05-28
2027-05-28
2027-05-29
Study completion EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05284747
2027-05-29
Primary completion EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05284747
2027-05-30
Study completion Management of the PDA Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03456336
2027-05-30
2027-05-30
2027-05-30
2027-05-30
Primary completion Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06733246
2027-05-30
Study completion Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06954155
2027-05-30
2027-05-30
Study completion A Phase 3 Study of HS-20094 in Patients With T2DM Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07156539
2027-05-30
2027-05-31
Study completion NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04055428
2027-05-31
Study completion GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06003153
2027-05-31
Primary completion GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06003153
2027-05-31
Study completion Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06528262
2027-05-31
Primary completion Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06528262
2027-05-31
Study completion A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06610526
2027-05-31
Primary completion A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06610526
2027-05-31
Primary completion Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06797401
2027-05-31
Primary completion Virtual Reality's Impact on Upper Limb Function in Post-stroke Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06881680
2027-05-31
Study completion Augmenting Cerebral Blood Flow in Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06911385
2027-05-31
Primary completion Augmenting Cerebral Blood Flow in Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06911385
2027-05-31
2027-05-31
Primary completion Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07049120
2027-05-31
Primary completion Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07249853
2027-05-31
2027-05-31
Primary completion Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07523620
2027-05-31
Study completion Ivabradine in the Acute Management of Cardiogenic Shock Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07714746
2027-05-31
Primary completion Ivabradine in the Acute Management of Cardiogenic Shock Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07714746
June 2027 167
2027-06-01
2027-06-01
2027-06-01
Primary completion Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04505618
2027-06-01
Study completion NeVa ONE Registry Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04562194
2027-06-01
Study completion The COCOA-PAD II Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04794530
2027-06-01
Primary completion SELUTION4BTK Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05055297
2027-06-01
Study completion Home BP Monitoring Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05552547
2027-06-01
Primary completion Home BP Monitoring Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05552547
2027-06-01
2027-06-01
2027-06-01
2027-06-01
2027-06-01
2027-06-01
Primary completion AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06235112
2027-06-01
Primary completion Acupuncture for Prediabetes With Combined Obesity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06359418
2027-06-01
2027-06-01
2027-06-01
2027-06-01
Study completion TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06802081
2027-06-01
Study completion Focused Orticumab Research for Treating Inflammation in Coronary Arteries Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06927739
2027-06-01
2027-06-01
2027-06-01
2027-06-01
Study completion Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07220525
2027-06-01
Primary completion Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07220525
2027-06-01
Primary completion Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07263035
2027-06-01
Primary completion Central Haemodynamics and Pacing for AV Block Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07276490
2027-06-01
Study completion Design and Rationale of the COLT Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07432529
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2018-08-01
Study start Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Registry record
Expected 2018-08-01; that period ended on 2018-08-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03262363
2018-08-01
Study start Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence Registry record
Expected 2018-08-01; that period ended on 2018-08-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03592823
2018-08-10
Study completion the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy Registry record
Expected 2018-08-10; that period ended on 2018-08-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03230851
2018-08
Primary completion Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01500590
2018-08
Study completion Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02007837
2018-08
Primary completion The European Bifurcation Club Left Main Study Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02497014
2018-08
Study completion The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02516826
2018-08
Primary completion The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02516826
2018-08
Study completion The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02646267
2018-08
Primary completion Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02770664
2018-08
Study completion Apixaban Dose Reduction in Patients With Elevated Drug Levels Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02809469
2018-08
Primary completion Apixaban Dose Reduction in Patients With Elevated Drug Levels Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02809469
2018-08
Study completion Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02919033
2018-08
Primary completion Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02919033
2018-08
Study start VitaFlowTM II Transcatheter Aortic Valve System Study Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03575039
2018-08
Study start DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris Registry record
Expected 2018-08; that period ended on 2018-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03633890
2018-09
Primary completion EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01084993
2018-09
Study completion Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01681381
2018-09
Study completion Mid-HDF Randomized Controlled Study on Outcome Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01693354
2018-09
Study completion Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02225756
2018-09
Primary completion Randomized All-comer Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02328898
2018-09
Study completion Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02484027
2018-09
Study completion High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02534155
2018-09
Primary completion Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02541877
2018-09
Study completion Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02655718
2018-09
Primary completion Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02655718
2018-09
Study completion Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02916485
2018-09-30
Study completion Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study Registry record
Expected 2018-09-30; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03398096
2018-09-30
Primary completion Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) Registry record
Expected 2018-09-30; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03486561
2018-09
Study start Optimizing Patient Usability Experience for Chronic Care Registry record
Expected 2018-09; that period ended on 2018-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03628963
2018-10-01
Primary completion Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring Registry record
Expected 2018-10-01; that period ended on 2018-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03426982
2018-10-30
Study completion Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring Registry record
Expected 2018-10-30; that period ended on 2018-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03426982
2018-10-30
Study start Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients Registry record
Expected 2018-10-30; that period ended on 2018-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03673241
2018-10
Study completion Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe Registry record
Expected 2018-10; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01661231
2018-10
Study completion Frailty and Cognitive Function Assessment of TAVI Patients Registry record
Expected 2018-10; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02650388
2018-10
Study completion Catheter Ablation of Longstanding Persistent Atrial Fibrillation Registry record
Expected 2018-10; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02929836
2018-10
Primary completion Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes Registry record
Expected 2018-10; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03159052
2018-10-31
Study completion Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) Registry record
Expected 2018-10-31; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03486561
2018-10
Study completion Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia Registry record
Expected 2018-10; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03639480
2018-10
Primary completion Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia Registry record
Expected 2018-10; that period ended on 2018-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03639480
2018-11-01
Study start tDCS to Treat Hemiplegic Shoulder Pain Registry record
Expected 2018-11-01; that period ended on 2018-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02929784
2018-11-25
Study start Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients Registry record
Expected 2018-11-25; that period ended on 2018-11-25.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03754738
2018-11
Study completion Sedation Depth in Neurocritical Care Registry record
Expected 2018-11; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02317497
2018-11
Primary completion Once-a-day Tacrolimus Conversion Study: The OneTAC Trial Registry record
Expected 2018-11; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02545972
2018-11-30
Study completion The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein Registry record
Expected 2018-11-30; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02562183
2018-11-30
Primary completion The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein Registry record
Expected 2018-11-30; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02562183
2018-11
Study completion Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Registry record
Expected 2018-11; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02607943
2018-11-30
Primary completion TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI Registry record
Expected 2018-11-30; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03145194
2018-11
Study completion Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) Registry record
Expected 2018-11; that period ended on 2018-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03249285
2018-12-01
Study start Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets Registry record
Expected 2018-12-01; that period ended on 2018-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03605433
2018-12-01
Study start Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Registry record
Expected 2018-12-01; that period ended on 2018-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03700645
2018-12-01
Study start Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response Registry record
Expected 2018-12-01; that period ended on 2018-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03715556
2018-12-01
Study start Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. Registry record
Expected 2018-12-01; that period ended on 2018-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03733002
2018-12-10
Study completion Development and Evaluation of a Novel Portable Robotic Gait Rehabilitation in Chronic Stroke Registry record
Expected 2018-12-10; that period ended on 2018-12-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03444688
2018-12-10
Primary completion Development and Evaluation of a Novel Portable Robotic Gait Rehabilitation in Chronic Stroke Registry record
Expected 2018-12-10; that period ended on 2018-12-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03444688
2018-12-20
Study start A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT Registry record
Expected 2018-12-20; that period ended on 2018-12-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03716011
2018-12-30
Study completion Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) Registry record
Expected 2018-12-30; that period ended on 2018-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02831088
2018-12-30
Primary completion Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) Registry record
Expected 2018-12-30; that period ended on 2018-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02831088
2018-12-30
Primary completion Local Paclitaxel or Balloon Angioplasty Below the Knee Registry record
Expected 2018-12-30; that period ended on 2018-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03149913
2018-12-30
Primary completion The Effects of Empagliflozin on Arterial Wall Characteristics Registry record
Expected 2018-12-30; that period ended on 2018-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03639545
2018-12
Study completion Study of the Orsiro Drug Eluting Stent System Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01356888
2018-12
Study completion Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01377285
2018-12
Primary completion Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01377285
2018-12-31
Study completion The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT01674686
2018-12-31
Primary completion The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT01674686
2018-12
Study completion ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01717911
2018-12
Study completion Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01913847
2018-12
Primary completion Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01913847
2018-12
Study completion The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01942109
2018-12
Study completion Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01983215
2018-12
Primary completion Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01983215
2018-12-31
Study completion Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02014818
2018-12
Primary completion External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02054416
2018-12
Study completion Stroke and Tocotrienol: Unique Role in Neuroprotection Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02263924
2018-12
Primary completion Stroke and Tocotrienol: Unique Role in Neuroprotection Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02263924
2018-12
Primary completion Eplerenone in the Management of Abdominal Aortic Aneurysms Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02345590
2018-12
Primary completion Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI) Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02512978
2018-12
Study completion Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02527811
2018-12
Primary completion Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02538978
2018-12
2018-12
Primary completion Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02625948
2018-12
Study completion A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02641652
2018-12
Primary completion Bioimpedance Analysis in Chronic Heart Failure Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02662439
2018-12
Study completion Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02666157
2018-12
Primary completion Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02666157
2018-12
Primary completion Self-Awareness of Symptoms, Signs and Medical Compliance Using a Patient Diary in Heart Failure Management Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02673073
2018-12
Primary completion Spironolactone in Atrial Fibrillation Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02673463
2018-12
Study completion In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02678065
2018-12
Primary completion In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02678065
2018-12
Study completion Adenosine as an Adjunct to Blood Cardioplegia Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02681913
2018-12
Study completion Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo. Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02715687
2018-12
Study completion Temporary Pacemaker in Transcatheter Aortic Valve Implantation Patients Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02768064
2018-12
Primary completion Integrative Care for Type 2 Diabetes Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02843724
2018-12
Study completion Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02901704
2018-12
Primary completion Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction. Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02919059
2018-12
Study completion Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02933788
2018-12
Study completion Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03027375
2018-12
Primary completion Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure Registry record
Expected 2018-12; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03027375
2018-12-31
Study completion Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03037047
2018-12-31
Study completion Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI Registry record
Expected 2018-12-31; that period ended on 2018-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03045562